Global views of proteasome-mediated degradation by mass spectrometry. (3rd August 2019)

• Record Type: Journal Article
• Authors: Javitt, Aaron; Merbl, Yifat
• Is Part Of: Expert review of proteomics. Volume 16:Number 8(2019)
• Page Start: 711
• Page End: 716
• Publication Date: 2019-08-03
• Subjects: Proteasome -- Proteasome footprinting -- degradation -- clinical proteomics; Proteins -- Biotechnology -- Periodicals; Proteomics -- Periodicals; 572.6
• DOI: 10.1080/14789450.2019.1651979
• Languages: English
• ISSNs: 1478-9450

Abstract

ABSTRACT: Introduction : Degradation of proteins by cellular proteasomes is critical for the fidelity of protein homeostasis and proper cell function. Indeed, perturbations in proteasome function, as well as the degradation of specific substrates, are associated with a variety of human diseases. Yet, monitoring and analyzing protein degradation in a high throughput manner in physiology and pathology remains limited. Areas covered : Here we discuss several of the recently developed mass spectrometry-based methods for studying proteasome-mediated cellular degradation and discuss their advantages and limitations. We highlight Mass Spectrometry Analysis of Proteolytic Peptides (MAPP), a method designed to purify and identify proteasome-cleaved cellular proteins as a novel approach in molecular and clinical profiling of human disease. Expert opinion : The recent improvement of proteomics technologies now offers an unprecedented ability to study disease in clinical settings. Expanding clinical studies to include the degradation landscape will provide a new resolution to complement the cellular proteome. In turn, this holds promise to provide both new disease targets and novel peptide biomarkers which will further enhance personalized proteomics.